Director, Clinical Research, Oncology @ (October 2010 - May 2013)
Director, Translational Medicine, Biotherapeutics R and D @ (March 2010 - October 2010)
Associate Director @ (October 2009 - April 2010)
Associate Director, Clinical Translational Medicine @ (January 2007 - December 2009)
Instructor @ (January 2002 - December 2007)
Associate Member @ (January 1997 - December 2002)
Robin Edwards Education
University of Pennsylvania School of Medicine
Pathology (Hematopathology)
Case Western Reserve University School of Medicine
M.D. (Pathology, Hematopathology)
(Resident, Pathology & Laboratory Medicine
Fellow, Hematopathology)
Robin Edwards Skills
Medical Research
Biopharmaceuticals
Biomarkers
Oncology
Drug Development
Clinical Research
Clinical Trials
Pharmaceutical Industry
Clinical Development
Translational Medicine
Genetics
Pharmacodynamics
Pathology
R&D
Drug Discovery
Assay Development
Biotechnology
Life Sciences
Translational Research
Research
Manufacturing
Validation
Supply Chain Management
Emerald
GMP
21 CFR Part 11
Lifesciences
Change Management
CAPA
GLP
Healthcare Management
Pharmaceutical Sales
Cross Functional Team Leadership
Project Management
Quality System
Regulatory Affairs
FDA
Process Improvement
Regulatory Submissions
Hospitals
Lean Manufacturing
Program Management
Organizational Development
Workforce Planning
Sop
Technology Transfer
Strategy
Robin Edwards Summary
Robin Edwards, based in United States, is currently a Vice President, Translational Medicine at MacroGenics, Inc.. Robin Edwards brings experience from previous roles at Robin H. Edwards Consulting, LLC, Dragonfly Therapeutics, Inc., Daiichi Sankyo, Inc. and Bristol-Myers Squibb. Robin Edwards holds a Pathology in Hematopathology @ University of Pennsylvania School of Medicine. With a robust skill set that includes Medical Research, Biopharmaceuticals, Biomarkers, Oncology, Drug Development and more. Robin Edwards has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Robin Edwards?
Find contact details for 700 million professionals.